Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Cyclin-dependent Kinase Inhibitor 2A (p16ink4a) Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma Chang, D. T., Pai, R., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Ford, J. M., Koong, A. C. ELSEVIER SCIENCE INC. 2009: S57
View details for DOI 10.1016/j.ijrobp.2009.07.150
View details for Web of Science ID 000270573600121